Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an update.
EZZ Life Science Holdings Limited announced the results of its Annual General Meeting, where the re-election of Mr. Glenn Cross as Director was withdrawn. Mr. Cross decided not to stand for re-election, and the company expressed gratitude for his contributions. CEO Mark Quinn will serve as interim Chair. The meeting also included the approval of a 7.1A mandate and the adoption of a remuneration report, reflecting ongoing governance and strategic adjustments within the company.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited is a life science company focused on improving quality of life and human health. The company invests in consumer health through e-commerce and distributes high-quality products via omnichannel models across Australia, New Zealand, China, and globally. EZZ is also expanding into the United States, a key growth market.
Average Trading Volume: 73,117
Technical Sentiment Signal: Buy
Current Market Cap: A$109M
See more data about EZZ stock on TipRanks’ Stock Analysis page.